Invesco
ATYR

Invesco’s aTyr Pharma ATYR Stock Holding History

Invesco’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.2K Buy
46,354
+121
+0.3% +$102 ﹤0.01% 3714
2025
Q4 		$36.2K Buy
46,233
+374
+0.8% +$307 ﹤0.01% 3728
2025
Q3 		$33.1K Sell
45,859
-552,149
-92% -$2.5M ﹤0.01% 3764
2025
Q2 		$3.03M Buy
+598,008
New +$2.35M ﹤0.01% 2413
2015
Q3 		– Sell
-18
Closed -$5K – 4013
2015
Q2 		$5K Buy
+18
New +$5.59K ﹤0.01% 4221

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco's ATYR Position: Q1 2026 in Review

Invesco increased its aTyr Pharma (ATYR) stake by 0.26% in Q1 2026, buying an estimated $102 and bringing the position to 46,354 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3714.

Invesco first reported a position in ATYR in Q2 2015 and has held it in 5 quarters since. The position peaked at $3.03M in Q2 2025. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • Invesco held 46,354 shares of aTyr Pharma worth $36.2K as of Q1 2026.
  • Invesco bought 121 aTyr Pharma shares in Q1 2026, an estimated $102.
  • aTyr Pharma made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3714 holding.
  • Invesco first reported a position in aTyr Pharma in Q2 2015 and has held it in 5 quarters since.
  • Invesco's aTyr Pharma position peaked at $3.03M in Q2 2025.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.